Opinion on the diagnosis and treatment of human trichinellosis
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The clinical diagnosis of trichinellosis is difficult because there are no pathogenic signs or symptoms and in diagnosing the infection epidemiological data are of great importance. Trichinellosis usually begins with a sensation of general discomfort and headache, increasing fever, chills and sometimes diarrhoea and/or abdominal pain. Pyrexia, eyelid or facial oedema and myalgia represent the principal syndrome of the acute stage, which can be complicated by myocarditis, thromboembolic disease and encephalitis. High eosinophilia and increased creatine phosphokinase activity are the most frequently observed laboratory features and the parasitological examination of a muscle biopsy and the detection of specific circulating antibodies will confirm the diagnosis. The medical treatment includes anthelmintics (mebendazole or albendazole) and glucocorticosteroids. Mebendazole is usually administered at a daily dose of 5 mg/kg but higher doses (up to 20 - 25 mg/kg/day) are recommended in some countries. Albendazole is used at 800 mg/day (15 mg/kg/day) administered in two doses. These drugs should be taken for 10 - 15 days. The use of mebendazole or albendazole is contraindicated during pregnancy and not recommended in children aged < 2 years. The most commonly used steroid is prednisolone, which may alleviate the general symptoms of the disease. It is administered at a dose of 30 - 60 mg/day for 10 - 15 days.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gamble, H. R., Bessonov, A. S., Ćuperlović, K., Gajadhar, A. A., Knapen, F. V., Noeckler, K., Schenone, H., & Zhu, X. (2000) · Veterinary Parasitology · doi:10.1016/s0304-4017(00)00354-x · Cited by 422
Trichinellosis: a worldwide zoonosis
Dupouy-Camet, J. (2000) · Veterinary Parasitology · doi:10.1016/s0304-4017(00)00341-1 · Cited by 233
Self-citationChemotherapy of Echinococcus infection in man with albendazole
Horton, R. J. (1989) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(89)90724-4 · Cited by 218
Clinical aspects of infection with Trichinella spp
Capó, V, & Despommier, D. D. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.1.47 · Cited by 208
Pharmacokinetics of albendazole in man
Marriner, S. E., Morris, D. L., Dickson, B., & Bogan, J. A. (1986) · European Journal of Clinical Pharmacology · doi:10.1007/bf00608219 · Cited by 196
Factors affecting the flow among domestic, synanthropic and sylvatic cycles of Trichinella
Pozio, E. (2000) · Veterinary Parasitology · doi:10.1016/s0304-4017(00)00344-7 · Cited by 189
Self-citationNew patterns of Trichinella infection
Pozio, E. (2001) · Veterinary Parasitology · doi:10.1016/s0304-4017(01)00427-7 · Cited by 188
Self-citationTrichinellosis: human disease, diagnosis and treatment
Kocięcka, W. (2000) · Veterinary Parasitology · doi:10.1016/s0304-4017(00)00352-6 · Cited by 177
New aspects of human trichinellosis: the impact of new Trichinella species
Bruschi, F., & Murrell, K. D. (2002) · Postgraduate Medical Journal · doi:10.1136/pmj.78.915.15 · Cited by 166
Self-citationTrichinellosis: the zoonosis that won't go quietly
Murrell, K. D., & Pozio, E. (2000) · International Journal for Parasitology · doi:10.1016/s0020-7519(00)00132-6 · Cited by 156
Self-citationEffect of mebendazole therapy during pregnancy on birth outcome
Silva, N. D., Sirisena, J., Gunasekera, D., Ismail, M. M., & de Silva, H. (1999) · The Lancet · doi:10.1016/s0140-6736(98)06308-9 · Cited by 150
Increased systemic availability of albendazole when taken with a fatty meal
Lange, H., Eggers, R., & Bircher, J. (1988) · European Journal of Clinical Pharmacology · doi:10.1007/bf00540964 · Cited by 129
Dexamethasone increases plasma levels of albendazole
Jung, H., Hurtado, M., Medina, M. T., Sánchez, M., & Sotelo, J. (1990) · Journal of Neurology · doi:10.1007/bf00314741 · Cited by 125
Comparison of Human Trichinellosis Caused by Trichinella spiralis and by Trichinella britovi
Pozio, E., Varese, P., Gómez-Morales, M. Á., Croppo, G. P., Pelliccia, D., & Bruschi, F. (1993) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1993.48.568 · Cited by 115
Self-citationClinical pharmacokinetics of high dose mebendazole in patients treated for cystic hydatid disease
Braithwaite, P., Roberts, M. S., Allan, R., & Watson, T. R. (1982) · European Journal of Clinical Pharmacology · doi:10.1007/bf00542462 · Cited by 106
Pozio, E., Sacchini, D., Sacchi, L., Tamburrini, A., & Alberici, F. (2001) · Clinical Infectious Diseases · doi:10.1086/318707 · Cited by 101
Self-citationFourestié, V., Douceron, H., Brugières, P., Ancelle, T., Lejonc, J. L., & Gherardi, R. K. (1993) · Brain · doi:10.1093/brain/116.3.603 · Cited by 90
Preparation and Characterization of Albendazole β-Cyclodextrin Complexes
Castillo, J. A., Palomo-Canales, J., Garcia, J. J., Lastres, J. L., Bolás-Fernández, F., & Torrado, J. J. (1999) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-100102294 · Cited by 89
Blinded, Placebo‐Controlled Trial of Antiparasitic Drugs for Trichinosis Myositis
Watt, G., Saisorn, S., Jongsakul, K., Sakolvaree, Y., & Chaicumpa, W. (2000) · The Journal of Infectious Diseases · doi:10.1086/315645 · Cited by 78
Assessing the risk of benzimidazole therapy during pregnancy
Bradley, M., & Horton, J. D. (2001) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(01)90338-4 · Cited by 77
Fröscher, W., Gullotta, F., Saathoff, M., & Tackmann, W. (2008) · European Neurology · doi:10.1159/000116271 · Cited by 61
Clinical Pharmacokinetics of Albendazole in Patients with Brain Cysticercosis
Jung, H., Hurtado, M., Sánchez, M., Medina, M. T., & Sotelo, J. (1992) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1992.tb03783.x · Cited by 59
A novel formulation of albendazole solution: oral bioavailability and efficacy evaluation
Torrado, S., López, M. L., Torrado, G., Bolás, F., Torrado, S., & Cadórniga, R. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00204-4 · Cited by 51
Fouresti�, V., Bougnoux, M., Ancelle, T., Liance, M., Roudot‐Thoraval, F., Naga, H. I., Pairon-Pennachioni, M., Rauss, A., & Lejonc, J. L. (1988) · Parasitology Research · doi:10.1007/bf00931188 · Cited by 47
Efficacy of Mebendazole and Albendazole against Trichinella spiralis in Mice
McCracken, R. O. (1978) · The Journal of Parasitology · doi:10.2307/3279659 · Cited by 42
Albendazole Versus Thiabendazole as Therapy for Trichinosis: A Retrospective Study
Cabie, A., Bouchaud, O., Houzé, S., et al. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.6.1033 · Cited by 35
Bekhti, A., & Pirotte, J. (1987) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1987.tb03186.x · Cited by 31
Lopez-Garcia, M. L., Torrado, S., Torrado, S., Martínez, A. R., & Bolás-Fernández, F. (1998) · Veterinary Parasitology · doi:10.1016/s0304-4017(97)00177-5 · Cited by 31
Treatment of Trichinosis with Mebendazole
Levin, M. L. (1983) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1983.32.980 · Cited by 24
Cited by
Epidemiology, Diagnosis, Treatment, and Control of Trichinellosis
Gottstein, B., Pozio, E., & Nöckler, K. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00026-08 · Cited by 866
Self-citationSystematics and Epidemiology of Trichinella
Pozio, E., & Darwin Murrell, K. (2006) · Advances in Parasitology · doi:10.1016/s0065-308x(06)63005-4 · Cited by 342
Self-citationAlbendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update
Chai, J.-Y., Jung, B.-K., & Hong, S.-J. (2021) · The Korean Journal of Parasitology · doi:10.3347/kjp.2021.59.3.189 · Cited by 286
Neglected tropical diseases: diagnosis, clinical management, treatment and control
Utzinger, J., Becker, S. L., Knopp, S., Blum, J., Neumayr, A. L., Keiser, J., & Hatz, C. F. (2012) · Swiss Medical Weekly · doi:10.4414/smw.2012.13727 · Cited by 265
Metadata
- Authors
- Bruschi, F., Dupouy-Camet, J., Kociecka, W., Pozio, E., & Bolas-Fernandez, F.
- Venue
- Expert Opinion on Pharmacotherapy
- Publisher
- Informa Healthcare
- Published
- 2002-08
- Volume
- 3
- Issue
- 8
- Pages
- 1117-1130
- ISSN
- 1465-6566 (ISSN-L)
- 1744-7666
- OpenAlex
- W1998913484
- Cited by
- 265
- References
- 29
- FWCI
- 5.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.